You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Request a contact

Stay informed

Live Chat

The 2DR Era

Explore dolutegravir based, 2-drug regimens for your diverse patient needs.

Dovato tile
Image of pill may not reflect the actual size.
Times are changing | 2DR Era

2DR: Meeting a clinical need

The HIV treatment landscape has changed dramatically over the past 30 years, with each decade serving as a foundation for the next to build upon. Today marks the beginning of the next era in HIV therapy...THE 2DR ERA. 1

  • A 20-year-old starting a 3-drug regimen may be on therapy for nearly 6 DECADES, which translates to MORE THAN 60,000 DOSES of individual medications 4
Timeline of HIV Treatment

References:

  1. A timeline of HIV/AIDS. https://www.hiv.gov/. Accessed November 2021
  2. Llibre JM, et al. J Antimicrob Chemother. 2016;71:856-861.
  3. Antiretroviral drugs used in the treatment of HIV infection. https://www.fda.gov/. Accessed November 2021
  4. The Antiretroviral Therapy Cohort Collaboration. Lancet HIV. 2017;4:e349-e356.
  5. Juluca Summary of Product Characteristics. Available from: https://www.medicines.ie/medicines/juluca-50-mg-25-mg-film-coated-tablets-34548/, last accessed November 2021
  6. Dovato Summary of Product Characteristics. Available from: https://www.medicines.ie/medicines/list/all/page-1/per-page-25?query=dovato last accessed November 2021

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions.

Trade marks are owned by or licensed to the ViiV Healthcare group of companies.